Australian Committee Wants HTA Review To Begin Early In 2023
Executive Summary
At its next meeting, the Australian committee responsible for reviewing the country's health technology assessment system will discuss feedback from stakeholders, including the pharmaceutical industry, on the draft terms of reference for the review.
You may also be interested in...
Australian HTA Review Preparations Gather Pace
The review of Australia’s health technology assessment policy and methods will start in earnest once the terms of reference have been finalized and an independent expert is in place to oversee the review.
Australian HTA Revamp Aims To Speed Access To New Technologies
Drug industry group Medicines Australia says that the review of the health technology assessment system must ensure that the real impact and benefits of new products for patients are taken into account in reimbursement decisions. Other areas to be explored include the use of real-world data and managing clinical and economic uncertainty.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.